Yunlong Richard Cao on X: It's critical to test how these RBD hotspots could combine to achieve max immune evasion without losing affinity to ACE2. After careful consideration, besides the emerging K478R/F456L

Thread by @yunlong_cao on Thread Reader App – Thread Reader App

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Thread by @yunlong_cao on Thread Reader App – Thread Reader App

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

PDF) Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Biomedicines, Free Full-Text

AI-driven prediction of SARS-CoV-2 variant binding trends from atomistic simulations